De Lemos-Bonotto M et al. |
A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment. |
2018 |
Eur J Gastroenterol Hepatol |
pmid:29227329
|
Watanabe N et al. |
The possible clinical impact of risperidone on P-glycoprotein-mediated transport of tacrolimus: A case report and in vitro study. |
2018 |
Biopharm Drug Dispos |
pmid:29055041
|
Sakai R et al. |
Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan. |
2018 |
Lupus |
pmid:28683654
|
Almeida-Paulo GN et al. |
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant. |
2018 |
Pharmacogenomics J. |
pmid:28094348
|
Liu Y et al. |
Delayed Initiation of Tacrolimus Is Safe and Effective in Renal Transplant Recipients With Delayed and Slow Graft Function. |
2018 |
Transplant. Proc. |
pmid:30316359
|
Hou Y et al. |
Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review. |
2018 |
Medicine (Baltimore) |
pmid:29901618
|
Majeed A et al. |
A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study. |
2018 |
Transpl Infect Dis |
pmid:29668074
|
Shi D et al. |
CYP3A4 and GCK genetic polymorphisms are the risk factors of tacrolimus-induced new-onset diabetes after transplantation in renal transplant recipients. |
2018 |
Eur. J. Clin. Pharmacol. |
pmid:29546446
|
Wan Q et al. |
Therapeutic Effect of 0.1% Tacrolimus Eye Drops in the Tarsal Form of Vernal Keratoconjunctivitis. |
2018 |
Ophthalmic Res. |
pmid:28803239
|
Charnaya O et al. |
Results of early treatment for de novo donor-specific antibodies in pediatric kidney transplant recipients in a cross-sectional and longitudinal cohort. |
2018 |
Pediatr Transplant |
pmid:29356221
|
Sugimoto K et al. |
Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. |
2019 |
Dig Dis |
pmid:30205400
|